drugset / Trial / NCT07307131

Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts

NCT07307131

Phase 2 Completed 64 enrolled Benha University
RandomizedParallel-groupSingle-blindTreatment

Summary

This study compares the effectiveness and safety of two different intralesional treatments for cutaneous warts: a combination of furosemide and digoxin versus polidocanol.

Timeline

Start
2024-09-01
Primary completion
2025-03-01
Completion
2025-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified 0.25 mg/ml Other
Subject Furosemide Other / unclassified 10 mg/ml Other
Comparator Polidocanol Other / unclassified 2 % Other